Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

General Electric Board Approves Healthcare Division Spinoff, Likely To Begin Trading On January 4

Published 01/12/2022, 13:07
Updated 01/12/2022, 14:10
© Reuters.  General Electric Board Approves Healthcare Division Spinoff, Likely To Begin Trading On January 4

Benzinga -

  • General Electric (NYSE:GE) Co's (NYSE: GE) board approved the previously announced spinoff of its healthcare business, GE Healthcare Holding LLC.
  • Before such a spinoff, GE HealthCare will likely be converted into a corporation and renamed GE HealthCare Technologies Inc.
  • The company will likely begin trading on Nasdaq on January 4, 2023, under the ticker "GEHC."
  • Also Read: How Boeing (NYSE:BA), GE And Raytheon (NYSE:RTN) Shares Are Reacting To $1.3B In New US Defense Contracts
  • The board approved a distribution to GE shareholders of at least 80.1% of the outstanding shares of GE HealthCare.
  • Holders of GE common stock will receive one share of GE HealthCare for every three shares of GE held on December 16, 2022, the record date for the distribution.
  • The distribution will likely occur after the U.S. market closes on January 3, 2023.
  • Effective upon the spinoff, GE will retain up to 19.9% of the outstanding shares of GE HealthCare.
  • GE put an initial value of $31 billion on the soon-to-be-public company, the Wall Street Journal reported.
  • Following the healthcare spinoff, it plans to separate its aerospace business from its power and renewable-energy units.
  • GE HealthCare, which makes MRI machines and other medical equipment, has about $18 billion in annual revenue, compared with GE's $74.2 billion in 2021.
  • Culp will be the non-executive chairman of the new board, and Arduini will also be a director.
  • GE's healthcare division plans to hold an investor day on December 8.
  • Price Action: GE shares traded higher by 0.30% at $86.23 premarket on the last check Thursday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.